That Was Easy! Moderna Execs Test Eight, Pump The Bait, Dump The Stock ($89 Million)

The high-flying biotech stock was forced to reckon with the confidence-draining impact of insider sales when StatNews reported on Wednesday that insiders have sold more than $89 million in stock so far this year. Statnews didn’t say where it obtained this info; that $89 million number is larger than the sales that have already been disclosed to the SEC.